Company Filing History:
Years Active: 2000
Title: The Innovative Contributions of Igor Fisch in Recombinant Binding Proteins
Introduction
Igor Fisch is a notable inventor based in Coton, GB, recognized for his pioneering work in the field of recombinant binding proteins and peptides. His innovative approach has led to a significant patent that enhances the production of peptides and polypeptides, contributing to advancements in medical research.
Latest Patents
Fisch holds a patent titled "Recombinant binding proteins and peptides," which involves DNA constructs consisting of a first exon sequence encoding a first peptide, a second exon sequence for a second peptide, and a third sequence encoding a heterologous intron. This intricate design facilitates transcription that splices out the intron, allowing for the efficient translation of a single chain product peptide or polypeptide. Additionally, the isolated nucleic acid constructs described in his patent are aimed at creating constructs for the expression of these essential biological molecules.
Career Highlights
Igor Fisch is affiliated with the Medical Research Council, a prominent institution known for its contributions to health and biomedical research. His tenure at this institute highlights his commitment to advancing scientific knowledge and fostering innovation. Fisch’s work exemplifies the integration of complex molecular biology with practical applications in health and medicine.
Collaborations
Throughout his career, Fisch has collaborated with esteemed coworkers such as Andrew David Griffiths and Kaspar Philipp Holliger. These collaborations reflect a strong network of researchers dedicated to pushing the boundaries of knowledge in the field of molecular biology and biotechnology.
Conclusion
Igor Fisch stands as an influential figure in the realm of recombinant technology, with his patent serving as a stepping stone for future breakthroughs in peptide and polypeptide production. His contributions through his affiliations and collaborations leave a lasting impact on medical research and innovation.